Bioxytran (BIXT) Minority Interest (2020 - 2024)
Bioxytran (BIXT) posted Minority Interest of -$694210.0 for Q2 2024, little changed sequentially from -$694210.0 in Q1 2024, and down 11.2% YoY from -$781773.6 in Q3 2023.
Bioxytran (BIXT) Minority Interest (2020 - 2024) Analysis & Trends
Bioxytran has reported Minority Interest for 5 years, with the latest figure at -$694210.0 in Q2 2024.
- Quarterly Minority Interest fell 11.2% year-over-year to -$694210.0 in Q2 2024, while the trailing twelve-month figure through Jun 2024 was -$694210.0 (down 11.2% YoY) and the FY2023 annual result came in at -$680886.0, down 15.28% from the prior year.
- Minority Interest steadied at -$694210.0 in Q2 2024 per BIXT's latest filing, from -$694210.0 in the prior quarter.
- Over five years, Minority Interest peaked at $1.2 million in Q1 2021 and troughed at -$694210.0 in Q1 2024.
- A 5-year average of -$131498.6 and a median of -$565099.0 in 2022 frame the typical range for Minority Interest.
- The sharpest annual moves came in 2022 and 2024: Minority Interest plunged 156.65% in 2022, then dropped 11.2% in 2024.
- Over 5 years, Minority Interest stood at $888091.0 in 2020, then plunged by 144.73% to -$397256.0 in 2021, then plunged by 48.68% to -$590628.0 in 2022, then declined by 15.28% to -$680886.0 in 2023, then retreated by 1.96% to -$694210.0 in 2024.
- According to Business Quant data, Minority Interest over the past three periods registered -$694210.0, -$694210.0, and -$680886.0 for Q2 2024, Q1 2024, and Q4 2023 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn |
| 10 | Bioxytran | 2.47 Mn | 2.22 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | -694,210.00 |
| Mar 31, 2024 | -694,210.00 |
| Dec 31, 2023 | -680,886.00 |
| Sep 30, 2023 | -659,063.00 |
| Jun 30, 2023 | -624,286.00 |
| Mar 31, 2023 | -623,522.00 |
| Dec 31, 2022 | -590,628.00 |
| Sep 30, 2022 | -539,570.00 |
| Mar 31, 2022 | -448,372.00 |
| Dec 31, 2021 | -397,256.00 |
| Sep 30, 2021 | 952,462.00 |
| Jun 30, 2021 | 1.09 Mn |
| Mar 31, 2021 | 1.18 Mn |
| Dec 31, 2020 | 888,091.00 |